Papers

1

Total Citations

3

H-Index

1

About

Dr. Fuhao Xu is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment. His most notable contribution is the development and validation of single-port robotic-assisted lobectomy and segmentectomy, a groundbreaking approach that reduces surgical trauma while maintaining oncologic efficacy. His 2025 study on this technique, already garnering 3 citations, demonstrates its safety and feasibility, positioning him at the forefront of robotic thoracic surgery. Dr. Xu’s work addresses critical challenges in lung cancer management, including improving postoperative recovery and expanding surgical access for complex cases. By integrating robotic precision with single-port access, he has opened new avenues for less invasive yet effective cancer surgery. His research has immediate clinical relevance, influencing surgical protocols and inspiring further innovation in robotic platforms. Dr. Xu’s contributions are particularly impactful for early-stage lung cancer patients, offering them reduced hospital stays and faster return to daily life. As his work gains recognition, it promises to shape the future of thoracic oncology, making him a key figure in the evolution of surgical care.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: First Affiliated Hospital of Guangzhou Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago